European Commission approves expanded use of Merck's Keytruda in bladder cancer. Sanofi & Lilly announce data from phase III studies on pipeline...
Vous n'êtes pas connecté
The European Commission approves GSK's RSV vaccine, Arexvy, for use in adults aged 50-59 years with increased risk of the disease.
European Commission approves expanded use of Merck's Keytruda in bladder cancer. Sanofi & Lilly announce data from phase III studies on pipeline...
The World Health Organisation has granted its first authorisation for an mpox vaccine in adults, produced by Bavarian Nordic A/S. This marks a...
The World Health Organisation has granted its first authorisation for an mpox vaccine in adults, produced by Bavarian Nordic A/S. This marks a...
The FDA okays AstraZeneca's Fasenra for treating adults with eosinophilic granulomatosis with polyangiitis. This is the second approved indication for...
The World Health Organization (WHO) has approved the use of an mpox vaccine for the first time, which it says should facilitate “timely and...
The World Health Organization (WHO) has approved the use of an mpox vaccine for the first time, which it says should facilitate “timely and...
GENEVA (AP) — The World Health Organization said Friday it has granted its first authorisation for use of a vaccine against mpox in adults,...
The World Health Organization said Friday it has granted its first authorization for use of a vaccine against mpox in adults, calling it an important...
The World Health Organization said Friday it has granted its first authorization for use of a vaccine against mpox in adults, calling it an important...
GENEVA (AP) — The World Health Organization said Friday it has granted its first authorization for use of a vaccine against mpox in adults, calling...